About Shenzhen Readline Technology
Located in Shenzhen’s Nanshan District, Readline operates a leading cosmetic lab powered by synthetic biotechnology. From its headquarters in the Chuangyi Technology Building, the company delivers:
- Advanced peptide and protein production
- Smart manufacturing at its 100-ton Zhuhai facility
- R&D driven by a team of experts (60% of total staff)
- Multiple international certifications including ISO9001:2015 and EFfCI GMP
Through its ReBioHub platform integrating biocomputing, enzyme engineering and green chemistry, Readline serves the growing biotechnology sector across China’s Greater Bay Area.
Frequently asked questions
Readline produces biochemical compounds through its ReBioHub technology platform:
- Molecular products
- Peptides
- Proteins
- Sugars
- Nucleic acids
- Production technologies
- Enzyme engineering
- Cell engineering
- Fermentation engineering
- Green chemistry processes
- Manufacturing capacity
- 100-ton annual production
- Smart factory operations
- Quality control systems
Readline maintains the following technical infrastructure:
| Category | Components |
|---|---|
| Technology Platform |
|
| R&D Team |
|
| Production Methods |
|
Readline operates manufacturing facilities in mainland China:
- Production Site
- Smart factory in Zhuhai
- 100-ton annual capacity
- Operational since 2023
- Quality Systems
- ISO9001:2015 certified facilities
- FDA cGMP compliant operations
- EFfCI GMP manufacturing
- Additional Certifications
- IFRC Halal certification
- Kosher certification
- FSSC 22000 certification
More details about Shenzhen Readline Technology
A leading biotechnology enterprise in Shenzhen
Readline, established in 2017, operates as a high-tech enterprise in Shenzhen’s dynamic Nanshan District. The company has positioned itself as a cosmetic lab and research facility, focusing on synthetic biotechnology applications.
Advanced technology integration
From its headquarters in the Chuangyi Technology Building, Readline operates the ReBioHub platform, which combines biocomputing, artificial intelligence, and green chemistry. This integration supports the development of innovative solutions in the biotechnology sector.
Research and development excellence
The company’s R&D team represents over 60% of its workforce, with half of the team holding advanced degrees. This expertise enables Readline to advance in enzyme engineering and fermentation processes, serving the cosmetic and biotechnology industries.
Manufacturing capabilities
In 2023, Readline expanded its operations with a 100-ton smart manufacturing facility in Zhuhai. This facility implements advanced automation systems and quality control measures, adhering to international standards.
Quality assurance and certifications
Readline maintains multiple international certifications, including:
- ISO9001:2015
- EFfCI GMP
- FDA cGMP
- FSSC 22000
- IFRC Halal
- Kosher
Specialized production capabilities
Operating from Guangdong province, Readline specializes in the production of:
- Peptides
- Proteins
- Sugars
- Nucleic acids
These components are manufactured using advanced synthetic biology methods, supporting both domestic and international markets.






